Carol Fabian, MD
Enriched profileUniversity Distinguished Professor of Medicine (Medical Oncology), Director of the Breast Cancer Prevention and Survivorship Research Center, holder of the Mark and Bette Morris Family Professorship in Cancer Prevention · University of Kansas Medical Center
Carol Fabian is University Distinguished Professor of Medicine (Medical Oncology), Director of the Breast Cancer Prevention and Survivorship Research Center, holder of the Mark and Bette Morris Family Professorship in Cancer Prevention at University of Kansas Medical Center. OpenAlex indexes 337 publications with 10,804 citations (h-index 47); ClinicalTrials.gov lists 29 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Carol Fabian, MD, is University Distinguished Professor of Medicine (Medical Oncology), Director of the Breast Cancer Prevention and Survivorship Research Center, holder of the Mark and Bette Morris Family Professorship in Cancer Prevention at University of Kansas Medical Center. The public record shows 337 publications with 10,804 citations (h-index 47), centered on Breast Cancer Treatment Studies, Estrogen and related hormone effects, Cancer Risks and Factors. It also documents an investigator role on 29 registered clinical trials, 10 NIH-funded awards (1986–2025).
- Most recent indexed publication: 2026 · Cancer prevention research (Philadelphia, Pa.)
- Top research focus: Breast Cancer Treatment Studies
- 29 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 120.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 29 registered studies on ClinicalTrials.gov. The most recent:
- Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
Sponsor: University of Kansas Medical Center
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Sponsor: National Cancer Institute (NCI)
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Sponsor: National Cancer Institute (NCI)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
54.2%Estrogen Agonist/Antagonist54.2%Tamoxifen Citrate100%Part D<11 patientsGenitourinary & hormones
45.8%Estrogen45.8%Estradiol (Twice Weekly)100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
10 NIH research awards on record, funded 1986–2025 per NIH RePORTER. The latest:
- Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer
University of Kansas Medical Center
FY2025$825,302R01CA249437 - Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer
University of Kansas Medical Center
FY2024$793,304R01CA249437 - Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer
University of Kansas Medical Center
FY2023$832,556R01CA249437
Congress activity
Updated 27 Aug 2026
62 congress contributions (2004–2025) across AACR, ASCO, SABCS per OpenAlex. The most recent:
- Acolbifene vs tamoxifen for breast cancer prevention in premenopausal women at high risk for breast cancer.
ASCO Annual Meeting
ASCO2025Presenting author - Abstract PO2-08-10: Effect of 6 months of bazedoxifene + conjugated estrogens on body composition and insulin resistance
AACR Annual Meeting
AACR2024Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Weight loss and omega-3 supplementation modulate the microbiome in women with increased breast cancer risk.
Cancer prevention research (Philadelphia, Pa.)
Article2026 - Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo.
Cancer prevention research (Philadelphia, Pa.)
Clinical Trial2021 - Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?
Clinical cancer research
Comment2021
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/C_wJ1Wzpp4M
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - X / Twitter
x.com/SABCSSanAntonio/status/1747314395724628306
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Clinical Fellowship in Medical Oncology (and Hematology/Immunology)
University of Kansas Medical Center
1977verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
- BA
University of Kansas
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - Internal Medicine Internship & Residency
Wesley Medical Center, Wichita, KS
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Breast Cancer Prevention and Survivorship Research Center, University of Kansas Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - Associate Director of Clinical Research
University of Kansas Cancer Center (NCI-Designated Cancer Center)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kucancercenter.org ↗ - Leader/Co-Leader
Cancer Prevention Program, University of Kansas Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kucancercenter.org ↗
Awards & honors
honors on the public record- Endowed professorship named in her honor: the Carol Fabian
MD, Professorship in Breast Cancer Research at The University of Kansas Cancer Center
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kucancercenter.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kucancercenter.org ↗
- Girl Scouts of NE Kansas and NW Missouri Pearl Award (2013)
honoring extraordinary women in science, technology, engineering and math
2013provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kucancercenter.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
Media & interviews
press, podcasts and appearances- "Carol Fabian on breast cancer prevention and tissue sampling using fine needle aspiration"
Q&A interview, The Cancer Letter / Cancer History Project (March 25, 2022), interviewed by Alexandria Carolan
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerhistoryproject.com ↗ - "A persistent pioneer in breast cancer research"
feature article, University of Kansas Cancer Center newsroom
2016verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kucancercenter.org ↗ - "Carol Fabian: A Persistent Pioneer in Breast Cancer Research"
profile feature, The Cancer History Project
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerhistoryproject.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center